Vector Laboratories
Ann Brighty has a diverse work experience spanning over several decades. Ann started their career as a Postdoctoral Research Fellow at Nottingham Trent University in 1985. Ann then worked as a Research Scientist at Biotal Ltd in 1987 and later became a Senior Technical Sales Specialist at Northumbria Biologicals in 1988.
In 1989, Ann joined Stratagene Ltd as a Senior Technical Sales Consultant and was responsible for establishing the UK sales operation for the company's subsidiary. Ann undertook various sales activities, including instrument demonstrations, trade shows, and managing a sales team. Ann continued to work at Stratagene Ltd and took on the role of UK Sales Manager and European Manager for Transgenic Assay Systems. Ann successfully identified and developed key accounts, leading to a 25% increase in sales. Additionally, they played a crucial role in expanding the business in Europe for a molecular toxicology system.
Ann's next career move was in 1995 when they joined Vector Laboratories Ltd as the Managing Director. Ann held this position for 25 years until 2020 when they transitioned to the role of Senior Business Development Director for the UK and Ireland.
Throughout their career, Ann Brighty has showcased their expertise in various roles, including research, sales, and management. Their contributions have led to business growth, increased sales, and the establishment of successful sales operations.
Ann Brighty attended Holy Cross Convent in Chalfont St Peter, Bucks from 1968 to 1978. Ann obtained their Bachelor of Science (BSc) degree in Joint Honours Microbiology and Genetics from Cardiff University/Prifysgol Caerdydd, completing their studies from 1978 to 1981. Ann then pursued their Doctor of Philosophy (PhD) degree in Genetics and biochemical studies of D-alanine dehydrogenase in Pseudomonas aeruginosa at Cardiff University/Prifysgol Caerdydd from 1981 to 1984.
This person is not in any offices
Vector Laboratories
Vector Laboratories, part of Maravai LifeSciences, pioneered and is a market leader in labeling and detection reagents for immunohistochemistry, immunofluorescence, glycobiology and bioconjugation. As the first company to commercialize avidin-biotin enzyme complex kits for immunohistochemistry and antifade mounting media for immunofluorescence, Vector has since introduced over 600 reliable reagents and kits. Its product catalog includes VECTASTAIN® ABC kits, VECTASHIELD® Mounting Media, ImmPRESS® Polymer Detection Kits, TrueVIEW® Autofluorescence Quenching Kit, ImmPACT® Substrates and SoluLINK® bioconjugation technology, which allows rapid, reproducible and quantifiable conjugation of all classes of biomolecules. These time-tested tools and methods are used by disease and therapeutics researchers around the world--from academia to industrial and clinical settings--to accelerate their lab processes and improve productivity. In fact, Vector’s labeling and detection reagents and processes are included in Standard Operating Procedures in labs around the world. Vector’s facilities are ISO 9001:2015 certified and its research contributions have been cited in more than 350,000 scientific publications. Located in the San Francisco Bay Area, Vector was founded in 1976 by Dr. Jim Whitehead, who dedicated the company to creating the highest performing products for researchers around the world. That same commitment is present today with the high level of both product and service that Vector Laboratories is known for.